Renalase Identified by Machine Learning Methods As A Novel Independent Predictor Of Mortality In Hospitalized Patients With COVID-19
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Among 437 hospitalized patients with COVID-19, XGBoost ranked low serum renalase among predictors of 180-day mortality. This single-cohort analysis had no external validation and does not establish renalase as a causal factor; it had also been discussed in earlier literature.
Technology: XGBoost ranked clinical and laboratory variables, including renalase, for 180-day mortality prediction.
Publication: Preprint · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- XGBoost ranked clinical and laboratory variables, including renalase, for 180-day mortality prediction.
- Limitation / still unknown
- Single cohort of 437 hospitalized patients, without external validation; the association does not establish renalase as causal and renalase was already discussed in prior literature.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.researchsquare.com/article/rs-2492699/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.